Anke Katharina Bergmann

14PUBLICATIONS
134CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|Jun 29, 2026
Sequence heterogeneity in pneumonia virus of mice reveals G gene-dependent modulation of virulence.

|Feb 13, 2026
Priority European strategies for sustainable access to high-quality genetic counselling in cancer: A Delphi study.

J Matt McCrary, Els Van Valckenborgh, Denis Horgan

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Mar 25, 2025
NGS-based IG/TR gene rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturation.

Michaela Kotrová, Constantin Proske, Nikos Darzentas

|Jan 08, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.

Rabia Shahswar, Razif Gabdoulline, Katja Krueger

Pageof 3

Frequent Collaborators

6 joint publications

Martin Schrappe

4 joint publications

Martin Zimmermann

3 joint publications

Andishe Attarbaschi

3 joint publications

Florian Heidel